Diagnostic accuracy of clinical tools for assessment of acute stroke : a systematic review by Antipova, Daria et al.
RESEARCH ARTICLE Open Access
Diagnostic accuracy of clinical tools for
assessment of acute stroke: a systematic
review
Daria Antipova1* , Leila Eadie1, Ashish Macaden2 and Philip Wilson1
Abstract
Introduction: Recanalisation therapy in acute ischaemic stroke is highly time-sensitive, and requires early
identification of eligible patients to ensure better outcomes. Thus, a number of clinical assessment tools have been
developed and this review examines their diagnostic capabilities.
Methods: Diagnostic performance of currently available clinical tools for identification of acute ischaemic and
haemorrhagic strokes and stroke mimicking conditions was reviewed. A systematic search of the literature
published in 2015–2018 was conducted using PubMed, EMBASE, Scopus and The Cochrane Library. Prehospital and
in-hospital studies with a minimum sample size of 300 patients reporting diagnostic accuracy were selected.
Results: Twenty-five articles were included. Cortical signs (gaze deviation, aphasia and neglect) were shown to be
significant indicators of large vessel occlusion (LVO). Sensitivity values for selecting subjects with LVO ranged from
23 to 99% whereas specificity was 24 to 97%. Clinical tools, such as FAST-ED, NIHSS, and RACE incorporating cortical
signs as well as motor dysfunction demonstrated the best diagnostic accuracy. Tools for identification of stroke
mimics showed sensitivity varying from 44 to 91%, and specificity of 27 to 98% with the best diagnostic
performance demonstrated by FABS (90% sensitivity, 91% specificity). Hypertension and younger age predicted
intracerebral haemorrhage whereas history of atrial fibrillation and diabetes were associated with ischaemia. There
was a variation in approach used to establish the definitive diagnosis. Blinding of the index test assessment was not
specified in about 50% of included studies.
Conclusions: A wide range of clinical assessment tools for selecting subjects with acute stroke has been developed
in recent years. Assessment of both cortical and motor function using RACE, FAST-ED and NIHSS showed the best
diagnostic accuracy values for selecting subjects with LVO. There were limited data on clinical tools that can be
used to differentiate between acute ischaemia and haemorrhage. Diagnostic accuracy appeared to be modest for
distinguishing between acute stroke and stroke mimics with optimal diagnostic performance demonstrated by the
FABS tool. Further prehospital research is required to improve the diagnostic utility of clinical assessments with
possible application of a two-step clinical assessment or involvement of simple brain imaging, such as transcranial
ultrasonography.
Keywords: Acute cerebral ischaemia, Clinical prediction rules, Emergency care, Intracerebral haemorrhage, Large
vessel occlusion, Recanalization, Stroke, Scoring methods, Thrombectomy, Thrombolysis
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: daria.antipova@abdn.ac.uk
1Centre for Rural Health, University of Aberdeen, Old Perth Road, Inverness
IV2 3JH, UK
Full list of author information is available at the end of the article
Antipova et al. BMC Emergency Medicine           (2019) 19:49 
https://doi.org/10.1186/s12873-019-0262-1
Rationale
Patients with acute stroke should have access to rapid
assessment and early intervention with specialist care for
optimal outcomes. Acute ischaemic stroke caused by a
large vessel occlusion (LVO) is associated with high
mortality rate of 80% [1] and can be optimally managed
with intravenous (IV) thrombolysis followed by mechan-
ical thrombectomy (MT). While IV thrombolysis can
currently be provided in many general hospitals, MT can
only be performed in specialised centres with neuroin-
terventional facilities.
Recanalization therapy must be delivered within the
first hours after symptom onset to improve functional
outcome [2, 3]. This requires a reliable triage system
for early identification of subjects eligible for reperfu-
sion therapy. It is also crucial to exclude intracranial
haemorrhage and stroke-mimicking conditions before
initiating therapy to avoid giving inappropriate or po-
tentially life-threatening IV thrombolysis. An ideal tri-
age system could potentially be used in prehospital
settings to determine both immediate care (particularly
in remote areas) and transfer arrangements to appro-
priate hospital facilities.
An increasing number of studies assessing the diagnos-
tic performance of clinical assessment tools has been seen
in recent years. A systematic review of stroke recognition
instruments in suspected stroke patients was performed
by Rudd et al. (2016) [4], and included studies that were
published before 10 August 2015. The current review fol-
lows directly on from this date, and has been designed
with the aim of answering the following questions:
1. What is the sensitivity and specificity of currently
available clinical assessment tools for detecting
subjects with ischaemic stroke due to LVO?
2. What is the sensitivity and specificity of currently
available clinical assessment tools for diagnosing
acute haemorrhagic stroke?
3. What is the sensitivity and specificity of currently
available clinical assessment tools for differentiating
between acute stroke and stroke-mimicking
conditions?
Table 1 Review inclusion and exclusion criteria
Domain Inclusion Exclusion
Study type Comparative observational studies Case reports
Prospective observational studies Selected case series
Cohort studies Literature review
Unselected case series Conference proceedings
Full text unavailable
Participants Human Non-human subjects
Adults Exclusively paediatric patients
Mixed paediatric and adult populations (where paediatric and
adult groups are not possible to identify separately)
Patients with ischaemic stroke (including patients with LVO), acute
haemorrhagic stroke, and/or stroke-mimicking conditions and
transient ischaemic attack
Exclusively patients with non-stroke conditions, such as sickle cell
disease, arteriovenous malformation, traumatic brain injury,
cerebral tumour, subarachnoid haemorrhage, vertigo etc.
Sample size ≥300 participants [6] Sample size < 300 participants
Setting Prehospital and in-hospital
Procedure Use of a clinical assessment tool, including clinical scales, individual
symptoms and signs designed for identification of patients with
ischaemic stroke, including subjects with LVO, acute haemorrhagic
stroke, and/or stroke-mimicking conditions
Exclusively assessing the diagnostic accuracy of a brain imaging
modality for identification of patients with acute stroke and/or
stroke-mimicking conditions
Aims/
outcomes
Diagnostic accuracy of clinical tools designed for identification of
patients with ischaemic stroke, including subjects with LVO, acute
haemorrhagic stroke, and/or stroke mimicking conditions
Exclusively assessing the prognosis of functional disability caused
by a stroke
Diagnostic accuracy of clinical tools designed for differentiation
between two main subtypes of stroke – ischaemic and
haemorrhagic
Exclusively evaluating factors associated with misdiagnosis of
stroke
Exclusively diagnosing stroke patients with no assessment of
clinical factors
Publication 2015–2018 Before January 2015
In English In languages other than English
Antipova et al. BMC Emergency Medicine           (2019) 19:49 Page 2 of 11
Methods
Protocol and registration
The registered protocol can be accessed on PROSPERO,
the international prospective register of systematic
reviews:
https://www.crd.york.ac.uk/PROSPERO/display_rec-
ord.php?RecordID=112492
Eligibility criteria
Inclusion and exclusion criteria are presented in Table 1.
Information sources
A systematic search of the literature was conducted in
October 2018, using a database-specific search strategy
for each of the following electronic databases: PubMed,
EMBASE, Scopus and The Cochrane Library.
Search strategy
The search strategy included the following combination
of multiple iterations of MeSH and keyword terms
relating to each component of the research questions:
intracranial hemorrhages, cerebral intraparenchymal
hematoma, cerebrovascular apoplexy, brain infarction,
acute stroke, brain ischemia, cerebrovascular occlusion,
cerebral infarction, transient ischemic attack, “stroke
mimic*”, prehospital emergency care, emergency care,
scoring methods, neurologic signs and symptoms, differ-
ential diagnosis, neurologic examination, predictive value
of tests, sensitivity and specificity, logistic models.
The search was restricted to human studies, English
language, adult participants, and publication years 2015–
2018. This restricted publication date range was chosen
to perform an updated analysis of the data available. A
systematic review by Rudd et al. (2016) included pro-
spective studies and excluded retrospective studies, re-
search within a known stroke population, tools that
were exclusively used by ambulance dispatchers or with
telecommunication systems [4]; however all of these
were included in our systematic analysis.
Study selection
Titles of studies retrieved using the search strategy were
screened by one of the review authors to identify studies
that potentially met the inclusion criteria outlined in
Table 1. The abstracts of those potentially eligible stud-
ies were independently assessed for eligibility by three
review team members. Any disagreements between them
over the eligibility of particular studies were resolved
through discussion with a fourth reviewer.
Eligible papers were tabulated and used in the qualita-
tive synthesis. Studies which reported diagnostic accur-
acy values such as sensitivity, specificity, and positive
and negative predictive values were included in the
quantitative meta-analysis.
Data collection process
A dedicated data extraction form was developed and
used to collect relevant information from the included
studies. The inclusion of information fields in the data
collection form was guided by the review questions. The
following components were assessed:
– study identification: name of the first author and
publication year;
– setting for the application of the studied clinical
tool: prehospital or in-hospital;
– inclusion/exclusion criteria for participants;
– sample size;
– name of the clinical assessment tool studied (where
applicable);
– clinical information collected;
– background of personnel collecting and interpreting
clinical information;
– diagnostic approach used to establish a final
diagnosis;
– diagnostic accuracy values: true positive, true
negative, false positive, false negative values, positive
and negative predictive values, and/or positive and
negative likelihood ratios, sensitivity and specificity.
As our analysis concerned only published data, no fur-
ther data were sought from investigators.
Risk of bias assessment in individual studies
Two review authors qualitatively assessed included stud-
ies for a risk of bias and concerns regarding their applic-
ability for each of three domains: patient selection, index
test, and flow and timing, in accordance with the QUA-
DAS-2 Tool quality assessment system [5]. A table
summarising risk of bias and applicability concerns was
constructed.
Data synthesis
The synthesis was performed in accordance with the
Cochrane guidelines for diagnostic test accuracy reviews.
The diagnostic accuracy data from each study were pre-
sented graphically by plotting sensitivities and specific-
ities on a coupled column chart.
Results
Study selection
The results of the study selection process are illustrated
in Fig. 1.
Study characteristics
The current review includes 25 new studies whereas
adding to Rudd et al’s review (2016) [4], which included
18 primary studies out of the total number of 5622 refer-
ences identified. The main characteristics of the studies
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included in the current review are presented in
Additional file 1.
In total, 25,642 cases were assessed across the included
studies published between 2015 and 2018. Participants
were recruited in the prehospital setting, or upon pres-
entation to the hospital, or both. Of the included studies,
16/25 (64%) were retrospective.
Risk of bias assessment in individual studies
A summary of bias and applicability concerns is pre-
sented in Additional file 2.
All included studies recruited consecutive patients.
Case-control methodology was avoided in all cases. Only
studies with a high sample size of more than 300 partici-
pants according to Meader et al’s (2014) classification
[6] were considered for inclusion to ensure greater reli-
ability of the study results. All included studies were
analysed against the adequate blinding criterion.
In 13/25 (52%) papers it was not specifically men-
tioned or was judged to be unclear whether the results
of clinical assessment (the index test) were interpreted
independently from those tests that were used to make a
final diagnosis (the reference test) [7–19].
The approach for establishing the final diagnosis was
described in all included studies. Hospital discharge
diagnosis was referred to as the gold standard in six
papers, brain or cerebral vessel imaging alone in 14
cases, and five papers used clinical assessment together
with imaging to establish the definitive diagnosis.
Diagnostic accuracy of clinical tools in selecting subjects
with LVO
More than 20 different clinical assessment tools with
optimal cut-offs for selecting subjects with ischaemic
stroke due to LVO were analysed in this review
(Table 2).
Sensitivity values ranged from 23% (NIHSS subitem
LoC 1a) to 99% (NIHSS≥4, NIHSS≥6, a combination of
reduced level of consciousness with inability to answer
questions, facial weakness, arm weakness, sensation loss,
and aphasia). Specificity ranged from 24% (OoH-
NIHSS≥1, CPSS≥1) to 97% (G-FAST = 4). For simplicity,
only those tools showing both sensitivity and specificity
values ≥80% (an arbitrarily chosen threshold) were se-
lected to be plotted (Fig. 2).
It was suggested by Beume et al. (2018) [19] that cor-
tical signs such as gaze deviation, aphasia or agnosia,
and/or neglect were more accurate predictors of LVO
than motor deficit alone (PPV 60%, NPV 94%). However,
as demonstrated in Fig. 2, FAST-ED ≥ 4 (PPV 80%, NPV
100%), NIHSS≥10 (PPV 78%, NPV 99%), and RACE≥5
(PPV 81%, NP 99%) had the best diagnostic accuracy for
Fig. 1 PRISMA flowchart. Outline of the study selection process using inclusion and exclusion criteria
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Table 2 Diagnostic accuracy values of clinical tools for selecting subjects with large vessel occlusion
Clinical assessment Se Sp PPV NPV AUC
ACT-FAST [18] 0.85 0.93 0.53 0.99 0.90
aNIHSS ≥1 [27] 0.95 0.31 0.40 0.92 –
a-NIHSS item profile A≥ 3 [37] 0.64 0.69 0.76 0.55 0.66
a-NIHSS item profile B≥ 2 [37] 0.75 0.64 0.76 0.63 0.71
a-NIHSS item profile C≥ 2 [37] 0.51 0.73 0.75 0.50 0.60
a-NIHSS item profile D≥ 2 [37] 0.76 0.61 0.75 0.62 0.70
a-NIHSS item profile E≥ 2 [37] 0.71 0.65 0.76 0.60 0.68
Aphasia;
Neglect/gaze deviation [19]
0.91 0.70 0.60 0.94 0.77
Arm weakness [14] 0.96 0.41 0.18 0.99 0.68
Arm weakness;
Leg weakness;
Dysarthria [20]
0.92 0.44 0.28 0.96 –
Bernese score 1≥ 5 [37] 0.73 0.79 0.85 0.66 0.76
Bernese score 2≥ 2 [37] 0.71 0.80 0.84 0.64 0.74
Bernese score 3≥ 2 [37] 0.67 0.86 0.88 0.63 0.75
Bernese score 4≥ 1 [37] 0.67 0.83 0.86 0.63 0.74
Bernese score 5≥ 3 [37] 0.77 0.83 0.87 0.70 0.79
CPSS ≥1 [27] 0.96 0.24 0.38 0.93 –
CPSS ≥2 [14, 26] 0.56–0.92 0.81–0.85 0.40–0.65 0.78–0.99 0.75–0.78
CPSS1≥ 2 [37] 0.59 0.77 0.80 0.55 0.66
CPSS2≥ 2 [37] 0.73 0.71 0.79 0.63 0.72
CPSSS ≥1 [37, 38] 0.60–0.86 0.80–0.87 0.88 0.59 0.71
CPSSS ≥2 [9, 10, 24, 27, 38] 0.59–0.83 0.40–0.89 0.66–0.77 0.77–0.83 0.72–0.80
CPSSS ≥3 [38] 0.51 0.93 – – –
CPSSS =4 [38] 0.25 0.96 – – –
C-STAT [13] 0.54 0.91 0.45 0.93 0.79
C-STAT ≥2 [8, 17, 18] 0.47–0.85 0.68–0.85 0.35–0.40 0.88–0.98 0.65–0.85
DIRECT criteria [16] 0.74 0.92 0.43 0.98 0.91
EMSA ≥3 [8] 0.75 0.50 – – 0.69
Expressive aphasia [14] 0.39 0.64 0.13 0.88 0.52
Facial weakness [14] 0.93 0.50 0.20 0.98 0.72
FAST = 3 [17] 0.84 0.44 0.32 0.90 0.53
FAST-ED [13] 0.62 0.84 0.40 0.94 0.84
FAST-ED ≥3 [26] 0.71 0.78 0.62 0.84 0.76
FAST-ED ≥4 [8, 18, 24, 26] 0.42–0.96 0.82–0.90 0.24–0.80 0.82–1.00 0.64–0.91
FPSS [13] 0.54 0.91 0.47 0.93 0.85
Gaze deviation [14] 0.84 0.73 0.30 0.97 0.79
G-FAST ≥3 [13, 17] 0.75–0.89 0.39–0.83 0.31–0.39 0.92–0.96 0.51–0.85
G-FAST =4 [13] 0.36 0.97 0.59 0.91
LAMS ≥4 [9, 14, 18] 0.57–0.94 0.74–0.85 0.28–0.66 0.78–0.99 0.70–0.89
mNIHSS ≥5 [37] 0.78 0.76 0.85 0.69 0.78
mNIHSS ≥7 [27] 0.77 0.77 0.62 0.87 –
MPSS ≥3 [27] 0.84 0.65 0.54 0.89 –
Neglect [14] 0.88 0.69 0.28 0.98 0.79
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Table 2 Diagnostic accuracy values of clinical tools for selecting subjects with large vessel occlusion (Continued)
Clinical assessment Se Sp PPV NPV AUC
Neglect/gaze deviation [14] 0.95 0.64 0.27 0.99 0.79
NIHSS ≥4 [14, 27] 0.93–0.99 0.24–0.46 0.15–0.46 0.93–0.99 0.62
NIHSS ≥5 [27] 0.90 0.54 0.49 0.92 –
NIHSS ≥6 [8, 14, 26, 27] 0.66–0.99 0.39–0.70 0.18–0.55 0.85–1.00 0.68–0.72
NIHSS ≥7 [27, 37] 0.81 0.72–0.77 0.59–0.84 0.72–0.89 0.79
NIHSS ≥8 [14, 24] 0.72–0.98 0.48–0.81 0.21–0.71 0.82–0.99 0.71
NIHSS ≥9 [8, 24, 27] 0.53–0.81 0.72–0.85 0.59–0.75 0.81–0.89 –
NIHSS ≥10 [14, 24, 26, 27, 39] 0.64–0.98 0.56–0.88 0.23–0.78 0.80–0.99 0.75–0.84
NIHSS ≥14 [27] 0.61 0.88 0.72 0.82 –
NIHSS-8 [13] 0.63 0.89 0.44 0.94 0.84
NIHSS-8≥ 8 [7] 0.81 0.75 0.52 0.92 0.82
NIHSS subitem – LoC (1a) [14] 0.23 0.81 0.14 0.88 0.52
NIHSS subitem – LoC (1b) [14] 0.60 0.56 0.16 0.91 0.58
NIHSS subitem – LoC (1c) [14] 0.49 0.68 0.17 0.91 0.59
NIHSS;
Absence of prestroke handicap (mRS≤ 2);
Hemineglect;
AF;
Female sex;
Total score cut-off ≥16 [39]
0.84 0.68–0.71 0.41–0.54 0.92–0.94 0.84
NIHSS symptom profile A or B [17] 0.76 0.65 0.40 0.90 0.68
OoH-NIHSS ≥1 [27] 0.96 0.24 0.38 0.93 –
PASS [13] 0.69 0.85 0.40 0.95 0.81
PASS ≥2 [9, 14, 17, 18, 24] 0.64–0.96 0.59–0.84 0.33–0.74 0.81–1.00 0.63–0.89
Pomona ≥1 [14] 0.98 0.50 0.21 0.99 0.74
Pomona ≥2 [14] 0.86 0.71 0.71 0.97 0.79
RACE ≥3 [37] 0.74 0.80 0.85 0.67 0.77
RACE ≥5 [8, 9, 16–18, 24, 26–28] 0.46–0.92 0.68–0.91 0.27–0.81 0.78–0.99 0.67–0.90
RACE V1 ≥ 4 [28] 0.85 0.56 – – 0.81
RACE V2 ≥ 4 [28] 0.85 0.62 – – 0.79
RACE V3 ≥ 3 [28] 0.89 0.48 – – 0.78
RACE V4 ≥ 4 [28] 0.87 0.56 – – 0.80
RACE V5 ≥ 4 [28] 0.83 0.57 – – 0.79
RACE V6 ≥ 4 [28] 0.83 0.63 – – 0.77
RACE V7 ≥ 3 [28] 0.87 0.51 – – 0.76
Reduced level of consciousness with inability to answer questions;
Leg weakness;
Dysarthria;
Gaze deviation [20]
0.96 0.39 0.27 0.98 –
Reduced level of consciousness with inability to answer questions;
Facial weakness;
Arm weakness;
Sensation loss;
Aphasia [20]
0.99 0.28 0.99 0.25 –
Reduced level of consciousness with inability to answer questions;
Leg weakness;
Neglect;
Gaze deviation [20]
0.85 0.45 0.26 0.93 –
rNIHSS (profile A, B, C, D or E vs. profile F) [27] 0.83 0.61 0.51 0.88 –
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selecting subjects with LVO. All three clinical assess-
ment tools incorporate cortical signs as well as motor
dysfunction.
The best sensitivity value of the combination of motor
deficit and cortical signs incorporated into the Finnish
Prehospital Stroke Scale (face drooping, limb weakness,
speech difficulty, visual disturbance, and conjugate eye
deviation) was for detection of proximal M1 occlusions
(100%) and the lowest – for M2 and basilar artery –
were 13 and 22%, respectively [13].
Moore et al. (2016) demonstrated that presence of all
four components forming a combination of reduced
Table 2 Diagnostic accuracy values of clinical tools for selecting subjects with large vessel occlusion (Continued)
Clinical assessment Se Sp PPV NPV AUC
ROSIER ≥4 [27] 0.79 0.76 0.61 0.88 –
sCPSSS (severe arm weakness, conjugate gaze deviation) ≥1 [38] 0.83 0.83
sCPSSS ≥2 [38] 0.59 0.90
sCPSSS =3 [38] 0.50 0.94
sNIHSS-1≥ 1 [37] 0.63 0.80 0.83 0.59 0.70
sNIHSS-1≥ 2 [27] 0.66 0.81 0.63 0.83
sNIHSS-5≥ 2 [37] 0.76 0.77 0.84 0.68 0.76
sNIHSS-5≥ 3 [24] 0.69 0.81 0.70 0.80 0.80
sNIHSS-5≥ 4 [27] 0.72 0.80 0.63 0.85 –
sNIHSS-8≥ 4 [37] 0.78 0.76 0.84 0.69 0.77
sNIHSS-8≥ 6 [24, 27] 0.64–0.77 0.78–0.88 0.63–0.78 0.79–0.88 0.82
sNIHSS-EMS ≥6 [24] 0.70 0.81 0.70 0.81 0.81
VAN [14] 0.95 0.56 0.23 0.99 0.77
Visual field defect [14] 0.88 0.75 0.33 0.98 0.82
3I-SS [9, 13] 0.42–0.50 0.92–0.93 0.45–0.77 0.77–0.92 0.71–0.78
3I-SS ≥1 [37] 0.73 0.78 0.83 0.65 0.75
3I-SS ≥2 [17] 0.65 0.72 0.42 0.87 0.71
3I-SS ≥4 [8, 24, 27] 0.19–0.40 0.94–0.95 0.74–0.85 0.71–0.74 0.65–0.80
Abbreviations: AUC area under the curve, NPV negative predictive value, PPV positive predictive value, Se sensitivity, Sp specificity
Fig. 2 Bar chart. Sensitivity and specificity values across the clinical tools for selecting subjects with large vessel occlusion
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consciousness level, lower limb weakness, dysarthria,
and gaze deviation had sensitivity of 96% and specificity
of 39% for LVO when compared with computed tomog-
raphy angiography (CTA) [20]. Thus, those who do not
have all four clinical features are less likely to have LVO,
and therefore would not require CTA, decreasing the
need for this test by about 32%. This approach might
also contribute to decisions about immediate transfer to
an endovascular centre for MT.
Diagnostic accuracy of clinical tools in detecting acute
haemorrhagic stroke
The paper by Jin et al. (2016) [21] was the single eligible
study for the present review that aimed to distinguish
between two main subtypes of stroke – ischaemic stroke
and haemorrhage. A total of 1989 cases from the Chin-
ese population with suspected first-ever acute stroke
were analysed. They proposed a discriminant function
model based on the following clinical assessment find-
ings: age above 65 years, past medical history of diabetes
(DM), atrial fibrillation (AF), systolic blood pressure
(SBP) above 180 mmHg, and vomiting at onset. It has
shown a higher sensitivity but lower specificity for
selecting subjects with ischaemic stroke (42–75.7% and
63.3–93.6%, respectively). Diagnostic accuracy values for
haemorrhage were the opposite of the above: low sensi-
tivity with higher specificity (58.5–93.6% and 42–79.2%,
respectively). It has also been suggested that a history of
AF and DM were more likely to be associated with
ischaemic stroke, whereas high SBP and younger age
were associated with haemorrhage.
Diagnostic accuracy of clinical tools for differentiating
between acute stroke and stroke-mimicking conditions
There was a significant variation in diagnostic accuracy
of tools designed for distinguishing between acute stroke
and stroke mimics as shown in Fig. 3.
Sensitivity values varied from 44% (LAPSS 1998) to
91% (sNIHSS-EMS). Specificity ranged from 27%
(MPDS) to 98% (LAPSS 1998) (Table 3). FABS showed
the best diagnostic accuracy values with 90% sensitivity
and 91% specificity [22].
The MPDS tool was developed to facilitate early iden-
tification of stroke or transient ischaemic attack by
emergency medical dispatchers to enable early notifica-
tion to receiving hospitals, and demonstrated satisfactory
sensitivity of 86% but low specificity of 27% (PPV 20%,
NPV 90%). Similarly, sNIHSS-EMS, which consisted of
six NIHSS items selected as “suitable for prehospital
use” [24] (level of consciousness, facial palsy, motor
arm/leg, sensory, language and dysarthria), had the high-
est sensitivity value (91%) when compared with other
clinical assessment tools but fairly low specificity (52%)
(PPV 43%, NPV 93%). In contrast, LAPSS 1998 and
LAPSS 2000 had the highest specificity (98 and 97%, re-
spectively) but the lowest sensitivity (44 and 49%, re-
spectively) values among the other tools [12, 15].
Fig. 3 Bar chart. Sensitivity and specificity values of clinical tools for differentiating between acute stroke and stroke-mimicking conditions
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The FABS tool was developed for identification of
subjects with stroke-mimicking conditions and negative
brain CT findings in the emergency department. The
total score is calculated based on the absent risk factors
for stroke (AF, hypertension, advanced age) and pres-
ence of sensory disturbance with no motor deficit.
FABS showed the best overall diagnostic accuracy
values of 90% sensitivity and 91% specificity (PPV 87%,
NPV 93%) [22].
Discussion
A reliable triage system that could allow emergency
transfer of patients eligible for MT directly to a regional
centre with neurointerventional facilities following early
IV thrombolysis (“drip and ship”) [25] could transform
stroke care. The present systematic review attempted to
evaluate the diagnostic accuracy of clinical assessment
tools for (1) selecting subjects with ischaemic stroke
due to LVO; (2) differentiating between two main sub-
types of stroke – ischaemic stroke and haemorrhage,
and (3) distinguishing between acute stroke cases and
stroke mimics.
All reviewed studies had a minimum sample size of
300 consecutive participants [6] leading to good reliabil-
ity of reported findings. There were however some limi-
tations found in the included studies which were mainly
related to unclear blinding of researchers interpreting
the results of the index and reference tests, and discrep-
ancy in the approach used to establish the gold standard.
As proposed by Beume et al. (2018) [19], cortical signs
such as aphasia or neglect are more accurate predictors
of LVO than motor deficit alone. However, a combin-
ation of signs suggestive of cortical involvement and
motor deficit, for example, as assessed by FAST-ED,
RACE or NIHSS scales, led to better diagnostic accuracy
when compared to the performance of cortical signs
alone as evaluated by the Pomona scale (Table 2).
Modest diagnostic accuracy was seen in clinical assess-
ment tools aiming to distinguish between acute stroke
and stroke mimics. The FABS tool which was designed
specifically for detecting stroke mimics and included
additional clinical information, such as atrial fibrillation
compared to other well-established tools, for example,
ROSIER, demonstrated high sensitivity and specificity
rates of about 90% (PPV 87%, NPV 93%) [22]. Clinical
assessment findings such as hypertension and younger
age were indicative of haemorrhage, whereas a history of
AF and DM were more likely to be associated with is-
chaemic stroke [21].
There are a few limitations of currently available tools
that possibly prevent them from being widely accepted.
First, their specificity rates for LVO remain quite low,
which could potentially lead to inappropriate transporta-
tion of patients at high cost [27]. Second, many studies
were designed in such a way that patients with haemor-
rhage and/or stroke-mimicking conditions were ex-
cluded, which therefore would preclude these clinical
tools from being applied to prehospital settings [19].
An ideal clinical assessment tool would be a simple
method that could be equally used in prehospital set-
tings and in emergency department with high predictive
values. It might be possible that a two-step approach
using two different clinical assessment tools at the pre-
hospital stage could be considered as an alternative op-
tion. The first step would be to select subjects with
acute stroke who would benefit from reperfusion therapy
and to exclude stroke mimicking conditions and acute
intracranial haemorrhage. For this purpose, a tool with
higher specificity should be considered, for example G-
FAST [13]. This might allow prehospital thrombolysis to
Table 3 Diagnostic accuracy values of clinical tools for selecting subjects with acute stroke and stroke-mimicking conditions
Clinical tool Target condition Se Sp PPV NPV AUC
CPSS [15] Acute stroke 0.83 0.69 0.50 0.91 –
FABS≥3 [22] Stroke mimic 0.90 0.91 0.87 0.93 –
FAST [12, 15] Acute stroke 0.76–0.85 0.64–0.68 0.50–0.93 0.30–0.92 0.70
GZSS≥1.5 [12] Acute stroke 0.83 0.74 0.95 0.42 0.87
LAPSS [12] Acute stroke 0.56 0.88 0.97 0.25 –
LAPSS 1998 [15] Acute stroke 0.44 0.98 0.87 0.82 –
LAPSS 2000 [15] Acute stroke 0.49 0.97 0.87 0.84 –
MASS [15] Acute stroke 0.63 0.94 0.79 0.87 –
Med PACS [15] Acute stroke 0.71 0.92 0.76 0.90 –
MPDS [23] Acute stroke 0.86 0.27 0.20 0.90 –
ROSIER [12, 15] Acute stroke 0.78–0.80 0.71–0.79 0.59–0.94 0.34–0.91 0.77
sNIHSS-EMS [24] Acute stroke 0.91 0.52 0.43 0.93 –
TriAGe+≥ 10 [11] Acute stroke 0.78 0.72 0.57 0.87 0.78
Abbreviations: AUC area under the curve, NPV negative predictive value, PPV positive predictive value, Se sensitivity, Sp specificity
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be offered to selected patients in remote areas in line
with management of patients with S-T elevation myocar-
dial infarction [29]. Thereafter, a decision on transferring
subjects with suspected LVO to a specialised centre
would be made on the basis of the clinical assessment
score with high sensitivity value, such as NIHSS or a
combination of clinical assessment findings as suggested
by Moore et al. [14, 20, 27]. However, this approach re-
quires further validation.
It might be beneficial to use an additional diagnostic
tool in combination with clinical assessment that could
provide valuable information and increase the accuracy
of such a triage system. Transcranial Doppler ultrasound
has been shown to detect occlusions in the major cere-
bral arteries with 68–100% sensitivity and 78–99% speci-
ficity [30–32]. It is a relatively inexpensive and readily
portable diagnostic tool that takes on average not more
than 15min to complete an examination of the cerebral
vessels [33], and can be used in prehospital settings, po-
tentially with remote diagnostic support [34–36]. How-
ever, further assessment and validation of this proposed
system is required.
Conclusion
A wide range of clinical assessment tools for selecting
subjects with acute stroke has been developed in recent
years. Assessment of both cortical and motor function
using RACE, FAST-ED or NIHSS demonstrated the best
diagnostic accuracy values for selecting subjects with
LVO. There were limited data on clinical tools that can
be used to differentiate between acute ischaemia and
haemorrhage. Diagnostic accuracy appeared to be mod-
est for distinguishing between acute stroke and stroke
mimics with optimal diagnostic performance demon-
strated by the FABS tool. Further research is required to
establish a novel prehospital triage system with possible
application of a two-step clinical assessment or involve-
ment of simple brain imaging, such as transcranial
ultrasonography.
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